Healthcare & Life Sciences

NUCLIDIUM

NUCLIDIUM is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 2 tracked investors.

Activeseries-b
series-b
Stage
2
Investors

About NUCLIDIUM

NUCLIDIUM is a startup based in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

NUCLIDIUM develops a new generation of radiopharmaceuticals for the diagnosis and therapy of cancer. Their technology aims to improve patient outcomes through targeted treatments.

Explore NUCLIDIUM's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Germany